Managed Care Calendar

  • ACC 59th Annual Scientific Session
    Start Date: 
    March 14, 2010
    End Date: 
    March 16, 2010
  • PCMA PBM Summit
    Start Date: 
    March 15, 2010
    End Date: 
    March 17, 2010
  • AMCP's 22nd Annual Meeting & Showcase
    Start Date: 
    April 7, 2010
    End Date: 
    April 10, 2010

Poll

Current Issue

  • Issue: 
    February 2010

    With Legislation Stalled, Reformers Regroup

    Confronted with public opposition, a unified minority party, and an election loss that changed the balance of power in the US Senate, healthcare reform efforts have entered a new phase featuring talk of bipartisan cooperation and a healthcare summit at the White House. Democrats continue to hold majorities in the House of Representatives and the Senate, but after months of debate and several narrowly won votes, their voluminous healthcare bills may no longer be viable. The opposition is calling for reformers to toss out the current Hous

  • Issue: 
    February 2010

    CMS Report Depicts Government’s Increasing Role

    Spending on healthcare in the United States totaled $2.5 trillion in 2009, a 5.7% increase, and accounted for 17.3% of the nation’s gross domestic product (GDP). Although job losses contributed to a reduction in private insurance enrollment, insurers saw better growth in private health insurance premiums than during 2008. Growth in public-sector healthcare spending outpaced increases in private outlays, and the government’s share of the national healthcare bill is projected to exceed 50% by 2012, according to projections rele

Opinion and Commentary

The Impact of Declining Walking Ability in the Multiple Sclerosis Patient

Log In or Register to view a pdf version

Acodra_diseasestateupdate1.jpg

Multiple sclerosis (MS) is a chronic, progressive disease of the central nervous system (CNS), characterized by inflammation, demyelination, and destruction of the motor and sensory axons within the brain and spinal cord.1 MS is thought to be an autoimmune disease.2 MS is the second most common cause of neurologic disability in working-age adults, affecting 400,000 individuals in the United States.2,3 Approximately 200 people in the United States are diagnosed every week. Globally, the disease affects about 2.5 million people.2 The disease is most often diagnosed in individuals between 20 a

GENOMIC-BASED ASSAYS ON DEMAND WEBCASTS

Managed Market News